Antibiotic options for enterococcus faecalis infections

Pakistan Journal of Medical Sciences

Volumn 22, Issue 3, 2006, Pages 286-290

  Abdulla, Farhan E ^a   Abdulla, Essa M ^a,b  

^a Dr Essa's Laboratory   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Enterococci; Fosfomycin; Nitrofurantoin; Treatment options; VRE

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT; ARTICLE; ASCITES FLUID; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; DRUG EFFICACY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PHYSICIAN; PUS; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; URINE CULTURE;

EID: 33748802573     PISSN: 1682024X     EISSN: 1682024X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Moellering RC Jr. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992; 14:1173-6.
2. rd edition), New York: Churchill Livingstone; 1990. Update Vol 2: 4.
3. Sharma A, Mong MS, Minamoto G. Enterococcus faecalis: An unusual cause of meningitis in HIV-infected patients. AIDS Read 2002; 12:540-2.
4. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant Enterococci during Vancomycin prophylaxis. J Clin Microbiol 1988: 26:1216-8.
5. Shlaes DM. Vancomycin-resistant bacteria. Infect Control Hosp Epidemiol 1992; 13:193-4.
6. Hayden MK, Harris AA. Confronting antibiotic resistance in enterococcal infections. Contemp Intern Med 1994; 6:7-17.
7. Leclercq R, Bingen E, Su CH. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother 1991; 35:92-8.
8. Moellering RC Jr, Cerwinka SL. Early clinical results with quinopristin/dalfopristin for the treatment of bacteremia due to resistant gram-positive bacteria. In: Zinner SH, Young LS, Acar JF, Neu HC, editors. Expanding Indications for the new Macrolides, Azalides, and Streptogramins. New York: Marcel Dekker; 1997:173-6.
9. Chernow JA. Studies expand fund of epidemiologic data on VRE. Infect Dis News 1994; 1-5.
10. Bauer AW, Kirby WMM, Sherris JC. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966; 45:493-6.
11. Malik N, Karamat KA, Butt T. Antimicrobial sensitivity testing for Enterococci by disk diffusion technique. Inf Dis J Pak 1998; 5:53-4.
12. AKUH Clinical Lab Antibiotic Sensitivity Report Jan-June 1997. J Pak Med Assoc 1998; 48(1):24.
13. Zhanel GG, Hoban DJ, Karlowsky JA. Nitrofurantoin is active against vancomycin-resistant Enterococci. Antimicrob Agents Chemother 2001; 45:324-6.
14. Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn Microbiol Infect Dis 2004; 50:201-4.
15. Seltzer E. Dalbavancin bests vancomycin for Gram-positive bacteremia. Clin Infect Dis 2005; 40:374-80.
16. Goosens H, Jabes D, Rossi R, et al. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of Ramoplanin against these isolates. J Antimicrob Chemother 2003; 52: 5-12.
17. th edition. New York, Lange Medical Books/McGraw-Hill, 2005; p.1531.
18. Chico RE. Antibiotic treatment of respiratory sepsis. Antibiot Chemother 1976; 21:115-6.
19. Legat FJ, Maier A, Dittrich P, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003; 47 (1):371-4.
20. Pfausler B, Spiss H, Dittrich P. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy- associated ventriculitis. J Antimicrob Chemother 2004; 53 (5):848-52.
21. Rodriguez A, Gallego A, Olay T, Mata JM. Bacteriological evaluation of fosfomycin in clinical studies. Chemotherapy 1977; 1:247-58.
22. th Annual Dow Medical College and Civil Hospital Symposium 1990.
23. Figueroa J, Baquero G, Otal C, Rodriguez A. Treatment of typhoid fever with fosfomycin alone and in association with chloramphenicol or ampicillin. Chemotherapy 1977; 23 (1):365-77.
24. Figueredo VM, Neu HC. Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. J Antimicrob Chemother 1988; 22: 41-50.
25. Allerberger F, Klare I. In vitro activity of fosfomycin against vancomycin-resistant enterococci. J Antimicrob Chemother 1999; 211-7.